Needham Heights, MA – Polestar Technologies, a leading provider of sensor systems for the biotechnology and pharmaceutical (biopharma) industries and Harvard Bioscience, Inc. a global developer, manufacturer and marketer of tools for life science research and regenerative medicine, have formed a partnership to bring new biosensing technologies to the regenerative medicine and tissue engineering marketplace. Through this partnership, Harvard Bioscience will have the right to sell Polestar Technologies’ sensor systems as stand-alone products or as integrated components of Harvard Apparatus’ physiology research systems and regenerative medicine bioreactors. The partnership also provides for the co-development of new sensors for this market.

According to “2020 Vision–A Future for Regenerative Medicine” from the US Department of Health and Human Services, the US market for regenerative medicine products is expected to be $100 billion. Harvard Bioscience estimates the nascent market for regenerative medicine tools could potentially grow to hundreds of millions of dollars annually. Harvard Bioscience is committed to bringing innovative and high-quality tools and expertise to this emerging market, and this is why they chose to partner with Polestar Technologies. Polestar Technologies has unique, patented, and accurate optical sensing products that measure O2, pH, and CO2 (in one system), critical factors in monitoring the growth of cells and tissues.

Ron Sostek, Vice President of Business Development for the Harvard Apparatus division of Harvard Bioscience stated, “We made a strategic decision to partner with Polestar Technologies given that they have both the expertise and the superior sensor solutions that allow us to bring a suite of powerful new research tools to our customers.” Rusty Warren, President of the Products Division of Polestar Technologies added, “We view this relationship as a true partnership because Harvard Apparatus is the standard for quality physiology R&D equipment and expertise, and Polestar Technologies is fast becoming the standard sensor provider for the regenerative medicine / tissue engineering market.”

About Polestar Technologies, Inc.

Founded in 1993, Polestar Technologies Inc. is a leading provider of optical monitors, sensors, and probes for lab, industrial, and commercial applications. Polestar manufactures monitors and sensors that are the standard for accurately measuring oxygen (O2), pH, and carbon dioxide (CO2) and makes the only monitor that measures all elements at once. The company also produces a variety of single use (disposable) sensors to service a variety of industries with a focus on the biotechnology and pharmaceutical (biopharma) and bioprocessing industries. In addition to its products, Polestar has a technology consulting division and also conducts sensor research and technology development for NIH, NASA, and DARPA as well as other government agencies. Polestar’s sensor products are the direct result of that research and are used by Fortune 100 companies worldwide. For more information, please visit http://www.polestartech.com/.

About Harvard Bioscience

Harvard Bioscience (“HBIO”) is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments, used to advance life science research and regenerative medicine. HBIO sells its products to thousands of researchers in over 100 countries primarily through its 850 page catalog (and various other specialty catalogs), its website, through distributors, including GE Healthcare, Thermo Fisher Scientific and VWR, and via our field sales organization. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain with additional facilities in France and Canada. For more information, please visit http://www.harvardbioscience.com.